189 related articles for article (PubMed ID: 36732336)
1. Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration.
Park C; Lee JW; Kim K; Seen DS; Jeong JY; Huh WK
Sci Rep; 2023 Feb; 13(1):1894. PubMed ID: 36732336
[TBL] [Abstract][Full Text] [Related]
2. LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration.
Hong JM; Lee JW; Seen DS; Jeong JY; Huh WK
Cell Commun Signal; 2023 Sep; 21(1):257. PubMed ID: 37749552
[TBL] [Abstract][Full Text] [Related]
3. Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer.
Fernández-Nogueira P; Noguera-Castells A; Fuster G; Recalde-Percaz L; Moragas N; López-Plana A; Enreig E; Jauregui P; Carbó N; Almendro V; Gascón P; Bragado P; Mancino M
Cancer Lett; 2018 Jun; 424():70-83. PubMed ID: 29548821
[TBL] [Abstract][Full Text] [Related]
4. G protein‑mediated EGFR transactivation is a common mechanism through which the CXCL12 receptors, CXCR4 and CXCR7, control human cancer cell migration.
Zieger-Naumann K; Kuhl F; Engele J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099418
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
6. SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.
Dillenburg-Pilla P; Patel V; Mikelis CM; Zárate-Bladés CR; Doçi CL; Amornphimoltham P; Wang Z; Martin D; Leelahavanichkul K; Dorsam RT; Masedunskas A; Weigert R; Molinolo AA; Gutkind JS
FASEB J; 2015 Mar; 29(3):1056-68. PubMed ID: 25466898
[TBL] [Abstract][Full Text] [Related]
7. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
[TBL] [Abstract][Full Text] [Related]
8. Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction.
Wang M; Wei X; Shi L; Chen B; Zhao G; Yang H
Int J Mol Med; 2014 Apr; 33(4):1019-26. PubMed ID: 24535227
[TBL] [Abstract][Full Text] [Related]
9. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
[TBL] [Abstract][Full Text] [Related]
10. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
Zhong P; Nakata K; Oyama K; Higashijima N; Sagara A; Date S; Luo H; Hayashi M; Kubo A; Wu C; He S; Yamamoto T; Koikawa K; Iwamoto C; Abe T; Ikenaga N; Ohuchida K; Morisaki T; Oda Y; Kuba K; Nakamura M
J Exp Clin Cancer Res; 2024 May; 43(1):138. PubMed ID: 38715057
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.
Nijmeijer S; Leurs R; Smit MJ; Vischer HF
J Biol Chem; 2010 Sep; 285(38):29632-41. PubMed ID: 20622011
[TBL] [Abstract][Full Text] [Related]
12. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
13. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway.
Francis H; Glaser S; Demorrow S; Gaudio E; Ueno Y; Venter J; Dostal D; Onori P; Franchitto A; Marzioni M; Vaculin S; Vaculin B; Katki K; Stutes M; Savage J; Alpini G
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C499-513. PubMed ID: 18508907
[TBL] [Abstract][Full Text] [Related]
14. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
17. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative Effect of Hesperidin Against Motion Sickness by Modulating Histamine and Histamine H1 Receptor Expression.
Deshetty UM; Tamatam A; Bhattacharjee M; Perumal E; Natarajan G; Khanum F
Neurochem Res; 2020 Feb; 45(2):371-384. PubMed ID: 31782104
[TBL] [Abstract][Full Text] [Related]
20. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling.
Wang J; Wang H; Cai J; Du S; Xin B; Wei W; Zhang T; Shen X
Exp Cell Res; 2018 Apr; 365(1):12-23. PubMed ID: 29453972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
